Skip to main content
Caplight Logo









TiliaHealth

TiliaHealth

Private
ViennaHealthcare & Life Scienceshttps://tiliah.com/

Last Round

Grant

Oct 1, 2024

Est. Valuation

$11,000

Total Funding Raised

$11,000

Company Overview

TiliaHealth is a digital health company that develops a platform for gamified assessment of symptoms of mental health disorders to enable mechanism-based diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Clinical Trials, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

digital biomarkersprecision psychiatryclinical outcome assessmentCOAgamified assessmentcomputational psychiatrymental health techdigital phenotypingbehavioral trackingpatient stratificationCNS drug developmentdigital health platformmental health appclinical research toolshealth SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TiliaHealth Comparables

Compare TiliaHealth with similar companies based on industry and business-model similarity.

TiliaHealth comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Deliberate AI
78%
Thymia
78%
Cambridge Cognition Holdings Plc
72%

TiliaHealth Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2024
Pre SeedMay 15, 2024

Key People

Founding team and executive leadership

Walter Sereinig

Chief Technology Officer

Executive Team

TiliaHealth Investors

Notable investors and investment history

TiliaHealth investors
InvestorRounds
University of InnsbruckGrant
FFG Austrian Research Promotion AgencyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 7, 2025

    Grew 60% QoQ, from 5 to 8 employees.

  • Jan 24, 2025

    Grew 400% QoQ, from 1 to 5 employees.

TiliaHealth Filings

Explore SEC and related filing metadata, where available.

TiliaHealth filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TiliaHealth's valuation, stock price, and market status.

Is TiliaHealth a public or private company?

TiliaHealth is a private company.

What is the current stock price of TiliaHealth?

TiliaHealth is a private company with no public stock price. Caplight tracks TiliaHealth's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is TiliaHealth worth (valuation)?

TiliaHealth's valuation is estimated at $11.0K based on funding round data.

Can I buy TiliaHealth stock?

TiliaHealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TiliaHealth's last funding round?

TiliaHealth's most recent funding round was Grant on May 15, 2024.

Who are the main investors in TiliaHealth?

Key investors in TiliaHealth include University of Innsbruck, FFG Austrian Research Promotion Agency.

Will TiliaHealth IPO soon?

No public IPO plans have been announced for TiliaHealth.

How can I track TiliaHealth secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TiliaHealth's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Employee Range12
Year Founded2024
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?